Mira Pharmaceuticals Inc (NASDAQ: MIRA) started the day on Thursday, with a price decrease of -6.29% at $1.34, before settling in for the price of $1.43 at the close. Taking a more long-term approach, MIRA posted a 52-week range of $0.73-$2.45.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -224.25%. Meanwhile, its Annual Earning per share during the time was -224.25%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 42.86%. This publicly-traded company’s shares outstanding now amounts to $17.39 million, simultaneously with a float of $12.19 million. The organization now has a market capitalization sitting at $25.55 million. At the time of writing, stock’s 50-day Moving Average stood at $1.4331, while the 200-day Moving Average is $1.2904.
Mira Pharmaceuticals Inc (MIRA) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – General Industry. Mira Pharmaceuticals Inc’s current insider ownership accounts for 41.55%, in contrast to 6.48% institutional ownership. According to the most recent insider trade that took place on Nov 19 ’24, this organization’s Chief Executive Officer sold 55,410 shares at the rate of 1.39, making the entire transaction reach 77,020 in total value, affecting insider ownership by 1,105,790. Preceding that transaction, on Nov 20 ’24, Company’s Chief Executive Officer sold 44,590 for 1.27, making the whole transaction’s value amount to 56,629. This particular insider is now the holder of 1,061,200 in total.
Mira Pharmaceuticals Inc (MIRA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year. Mira Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 42.86% and is forecasted to reach 0.22 in the upcoming year.
Mira Pharmaceuticals Inc (NASDAQ: MIRA) Trading Performance Indicators
Let’s observe the current performance indicators for Mira Pharmaceuticals Inc (MIRA). It’s Quick Ratio in the last reported quarter now stands at 2.79.
In the same vein, MIRA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.48, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be 0.22 at the market close of one year from today.
Technical Analysis of Mira Pharmaceuticals Inc (MIRA)
If we take a close look at the recent performances of Mira Pharmaceuticals Inc (NASDAQ: MIRA), its last 5-days Average volume was 0.33 million that shows plunge from its year to date volume of 1.71 million. During the previous 9 days, stock’s Stochastic %D was recorded 8.41% While, its Average True Range was 33.08.
Raw Stochastic average of Mira Pharmaceuticals Inc (MIRA) in the period of the previous 100 days is set at 19.57%, which indicates a major rise in contrast to 2.15% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1050 that was lower than 0.1120 volatility it exhibited in the past 100-days period.
